Literature DB >> 26215727

Nonparametric inference for time-dependent incremental cost-effectiveness ratios.

Laura M Yee1, Kwun Chuen Gary Chan1.   

Abstract

As the costs of medical care increase, more studies are evaluating cost in addition to effectiveness of treatments. Cost-effectiveness analyses in randomized clinical trials have typically been conducted only at the end of follow-up. However, cost-effectiveness may change over time. We therefore propose a nonparametric estimator to assess the incremental cost-effectiveness ratio over time. We also derive the asymptotic variance of our estimator and present formulation of Fieller-based simultaneous confidence bands. Simulation studies demonstrate the performance of our point estimators, variance estimators, and confidence bands. We also illustrate our methods using data from a randomized clinical trial, the second Multicenter Automatic Defibrillator Implantation Trial. This trial studied the effects of implantable cardioverter-defibrillators on patients at high risk for cardiac arrhythmia. Results show that our estimator performs well in large samples, indicating promising future directions in the field of cost-effectiveness.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Fieller bands; cost-effectiveness analysis; induced informative censoring; nonparametric estimation; randomized clinical trials; survival analysis

Mesh:

Year:  2015        PMID: 26215727      PMCID: PMC4715709          DOI: 10.1002/sim.6594

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  24 in total

1.  On estimating medical cost and incremental cost-effectiveness ratios with censored data.

Authors:  H Zhao; L Tian
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Using inverse-weighting in cost-effectiveness analysis with censored data.

Authors:  A R Willan; D Y Lin; R J Cook; E B Chen
Journal:  Stat Methods Med Res       Date:  2002-12       Impact factor: 3.021

3.  Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

Authors:  A R Willan; B J O'Brien
Journal:  Health Econ       Date:  1996 Jul-Aug       Impact factor: 3.046

4.  Marginal analysis of recurrent events and a terminating event.

Authors:  R J Cook; J F Lawless
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

Review 5.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

Authors:  A H Briggs; D E Wonderling; C Z Mooney
Journal:  Health Econ       Date:  1997 Jul-Aug       Impact factor: 3.046

6.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

7.  Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis.

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

8.  In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.

Authors:  B J O'Brien; M F Drummond; R J Labelle; A Willan
Journal:  Med Care       Date:  1994-02       Impact factor: 2.983

9.  Cost analysis with censored data.

Authors:  Yijian Huang
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

10.  Time to incorporate time in cost-effectiveness analysis.

Authors:  Gijs van de Wetering; Willem H Woertman; Eddy M Adang
Journal:  Eur J Health Econ       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.